FIRM FIXED PRICENO SET ASIDE USED.

DYNAVAX TECHNOLOGIES CORPORATION - 2024 ADULT VACCINES

PIID: 75D30124D19079Solicitation ID: 75D301-24-R-72943

Signed Date: Dec 4, 2025Effective Date: Jul 1, 2024

Award $

$3.9M

Vendor

DYNAVAX TECHNOLOGIES CORPORATION

NAICS

325412

Signed Date

Dec 4, 2025

Key Details

Dollars Obligated

$3.9M

Base & All Options

$5,000

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Centers for Disease Control and Prevention

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Description

2024 ADULT VACCINES

Context & Analysis

On Dec 4, 2025, Department of Health and Human Services obligated $3,923,889.3 to DYNAVAX TECHNOLOGIES CORPORATION for 2024 adult vaccines. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 8 offers received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.